RLAY Historical PE Ratio image   This RLAY PE ratio history page last updated 11/7/2022
RLAY Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/3/2022
20.94-0.76-3.04NA
Q2 2022
8/4/2022
19.16-0.71-2.84NA
Q1 2022
5/5/2022
23.30-0.57-2.28NA
Q4 2021
2/24/2022
21.70-0.62-2.48NA
Q3 2021
11/10/2021
33.74-0.66-2.64NA
Q2 2021
8/12/2021
33.52-0.64-2.56NA
Q1 2021
5/13/2021
27.50-0.47-1.88NA
Q4 2020
3/25/2021
35.574.5218.082.0
Q3 2020
11/12/2020
47.69-3.00-12.00NA
RLAY PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/3/2022
20.94-0.76-2.04NA
Q2 2022
8/4/2022
19.16-0.71-1.90NA
Q1 2022
5/5/2022
23.30-0.57-1.85NA
Q4 2021
2/24/2022
21.70-0.62-2.39NA
Q3 2021
11/10/2021
33.74-0.662.7512.3
Q2 2021
8/12/2021
33.52-0.640.4181.8
Q1 2021
5/13/2021
27.50-0.47NANA
Q4 2020
3/25/2021
35.574.52NANA
Q3 2020
11/12/2020
47.69-3.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree RLAY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Relay Therapeutics (RLAY) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RLMD PE Ratio History
RLYB PE Ratio History
RMD PE Ratio History
RMED PE Ratio History
RMTI PE Ratio History
RNA PE Ratio History
RNAZ PE Ratio History
RNXT PE Ratio History
RPHM PE Ratio History
RPID PE Ratio History
How should the RLAY historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Relay Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RLAY Historical PE Ratio page.

What is the average historical PE for RLAY based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RLAY historical PE ratio using the annualized quarterly earnings method works out to 2.0.

What is the average historical PE for RLAY based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RLAY historical PE ratio using the TTM earnings method works out to 47.0.

On this page we presented the RLAY Historical PE Ratio information for Relay Therapeutics' stock. The average RLAY historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RLAY historical PE based on this TTM earnings result method is 47.0. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RLAY historical PE result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for RLAY had been 20.49, and the most recent quarterly earnings result, annualized, was 18.08. Meanwhile, the most recent TTM earnings summed to 2.75. From these numbers, we calculate the recent RLAY PE on 11/4/2022 based on annualized quarterly EPS was 1.1. Based on RLAY's history, that recent PE is low relative to the historical average, with the recent PE 45.0% lower than the historical average PE across our data set for Relay Therapeutics. Looking at the recent RLAY PE on 11/4/2022 based on TTM EPS, we calculate the ratio at 7.5. Based on RLAY's history, that recent PE is low relative to the historical average, with the recent PE 84.0% lower than the average PE across our Relay Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on RLAY or any other given stock, valuation analysis for RLAY can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Relay Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RLAY. Thanks for visiting, and the next time you need to research RLAY Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ASUR Average Annual Return, COF Options Chain, PHAT YTD Return.

 

RLAY Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.